The past several days I've watched TNGN inch up yet I don't see any news driving this. Can anyone tell me why stock is increasing? Thank you.
FYI I've held stock over a year debating whether to sell. I think future is good but maybe immediate future a tough go on stock price.
Could inching up reflect a large buyer? Anyone speculate on this?
In the past when a Biotech firm posted clinical trial results like TNGN just reported--you'd see a pop in the stock price but TNGN went down.
These are very odd economic times for sure. Small cap Biotech stocks live/die on PR news releaases on clinical trials and TNGN did not move north but South. Odd!
I'm long TNGN but if succesful clinical trials don't move a stock upward Im not sure what will. Any thoughts on this dichotomy?
Agree with all but reason 5. To large investors like J & J--their investment in TNGN is chump change compared to the money they generate. Still nicely written I hope you are right.
I could be just optimistic but when volume spikes 7x--it can be some inside info on trials was leaked. For a small cap stock to trade 7x on no public news is unusual. hopefully some good news will follow soon
well said, the poster named Mickey has to be an idiot--shorting a stock at 50 cents. Anyone with sense would be shorting stocks who have more volume and higher stock price. he's just trying to talk the stock down but talk of dilution is a red herring as you pointed out. well done.
how dumb are you? Shorting a stock at 58 cents--how much lower do you think it can go?
your risk reward ratio is something like it could go up dollars--you can only gain 20-30 cents shorting--why bother. Why don't you move on to a fortune 500 firm.
It still doesn't make sense--management can't appoint board members only shareholders can elect IMHO. The proxie said they are looking for strategic investors so a buyout would be a good thing. I was also a little concerned the venture capitalist on the board left--this board needs a businessman not another member with a medical degree.
I'm a shareholder and I'm a little confused. The company keeps appointing board members. Aren't shareholders given an opportunity to elect them in this company? I'm an owner, management shouldn't be able to appoint their own board--I should have a say in it? Am I out of line here?
I don't know--I wouldn't mind a dividend and Ford's stock price is more related to systemic effects (i.e the economy) which they can't control. The price will turn up when confidence is restored in America and this will only occur when Obama is out of office as no one has any faith in his leadership anymore.
I just bought 5000 shares and think this is an excellent time to buy a speculative stock that could explode in the future.
1. Leading edge research--it is the future
2. Expect election year stimulus
3. low price now just 90 cents but could be worth $10 or more in the future when successful trials are concluded.
Bottom line, excellent speculation stock to load up on while price is so low.
I hope the managment realizes they need to start a PR buzz. It doesn't cost much to release a press release--news organizations are hungry for content. Here is excelent story in a UK newspaper on growing new organs.
Spare body parts could be grown in factories in years after scientists implant lab-produced organs in humans
By Alanah Eriksen
Last updated at 8:55 AM on 5th September 2011
Comments (13) Add to My Stories Share Spare human parts grown in laboratories could be just years away after scientists discovered more than 20 ways of growing organs.
They have already grown the bladder, urethra and windpipe which have been implanted into patients during clinical trials.
Now scientists have set their sights on replicating more complicated organs, including the heart, kidneys, liver, pancreas and thymus.
The advances could extend life expectancy and cut waiting times for transplants.
Developments: Spare human parts grown in laboratories could be just years away after scientists discovered more than 20 ways of growing organs
The developments were detailed at a conference on 'rejuvenation technologies' at Cambridge University, reported the Sunday Times.
Organiser Aubrey de Gray explained: 'We are seeing the emergence of a new era of medicine where the diseases of aging can be blocked or even reversed. These therapies are mostly in research now but eventually they will be commonplace.'
One of the speakers, Professor Paolo Macchiarini, of the Karolinska institute in Sweden, told how he impanted a laboratory-grown windpipe into a man sticken by throat cancer.
More...'Tiny radioactive beads helped me beat bowel cancer' tells miracle patient
'Catastrophic impact' on family as baby is buried without brain because hospital staff left it on a shelf for FIVE months
It had been created by using an artificial 'scaffold' designed in the shape of a windpipe which was impanted with the patient's stem cells.
'This could open new and very promising therapeutic possibilities for the thousands of patients who suffer from conditions that constrict the airway,' Mr Macchiarini said.
Professor Doris Taylor of Minnesota University, has already created a beating human heart by stripping dead cells from a donor organ and reseeding it with live ones.
They have already grown the bladder, urethra and windpipe which have been implanted into patients during clinical trials., now scientists have set their sights on replicating more complicated organs like the heart
And Professor Shay Soker of Wake Forest University in North Carolina, has created miniature human livers by seeding the protein skeleton from a rat's liver with human liver stem cells.
But there is one organ that can never be grown in a lab - the brain.
But scientists are trailing a drug called rilmenidine to help tackle Huntingtin's diseases which causes dementia and eventual death.
They hope it will boost the action of lysosomes which remove waste proteins that build up. Lysosomes weaken with age
Read more: http://www.dailymail.co.uk/health/article-2033599/Spare-human-parts-factory-years-away-scientists-discover-possible-grow-new-organs.html#ixzz1XBVEFMhP
the company needs to get its Public relation act together to start creating a buzz. Their products lend itself to this but they are just letting the stock die while waiting on results of clinical trials. PR campaigns don't cost much lot less than R &D.
Reading this board is sad but people one doesn't
make money overnight. Investing in any internet stock
is speculation because they are unproven as stand
alone businesses. Some will be hugely successful and
this may include AMEN but it will take several
Amen rode the internet wave because it had ".com" in
its name but one should not be putting money at risk
unless they understand the basic business fundamentals.
Painfully, I learned this from experience which is why i
feel bad for anyone who thought this new company was
initially worth $30.
It may get there sometime in
future when the profits show a support price of $30 etc.
Simply speaking Asia is not buying at previous
rates because they are in a severe
recession/depression. Thus more supply less demand for oil. Asia
significantly impacts oil.
Asia reforming? Have you ever
worked internationally? South Korea has made an attempt
but Japan etc are like a dear caught in a headlight.
They are spinning their wheels. This is going to take
many many years to turn around.
Like the concept of the company but clearly
valuation seems to be based on recent internet buzz word
attractiveness. In last two hours demand has significantly
curtailed. I've been long, got out and now I'm shorting this
puppy. Sorry but hope to ride the wave both